These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 25405753

  • 21. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T, Kondo K, Yamasoba T, Suzuki M, Sugasawa M, Kaga K.
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
    Yu QQ, Wu H, Huang X, Shen H, Shu YQ, Zhang B, Xiang CC, Yu SM, Guo RH, Chen L.
    Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Molecular biology of cholesteatoma.
    Maniu A, Harabagiu O, Perde Schrepler M, Cătană A, Fănuţă B, Mogoantă CA.
    Rom J Morphol Embryol; 2014 Mar; 55(1):7-13. PubMed ID: 24715159
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Biology of cholesteatoma: special considerations in pediatric patients.
    Preciado DA.
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):319-21. PubMed ID: 22264818
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Upregulation of let-7a inhibits vascular smooth muscle cell proliferation in vitro and in vein graft intimal hyperplasia in rats.
    Cao H, Hu X, Zhang Q, Wang J, Li J, Liu B, Shao Y, Li X, Zhang J, Xin S.
    J Surg Res; 2014 Nov; 192(1):223-33. PubMed ID: 24953987
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
    Schilling V, Bujia J, Negri B, Kastenbauer E.
    Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
    [Abstract] [Full Text] [Related]

  • 35. Increased expression of p63 and survivin in cholesteatomas.
    Park HR, Min SK, Min K, Jun SY, Seo J, Kim HJ.
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [Abstract] [Full Text] [Related]

  • 36. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q, Wei Q, Li X, Wang J, Zeng H.
    Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
    [Abstract] [Full Text] [Related]

  • 37. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V, Negri B, Bujía J, Schulz P, Kastenbauer E.
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [Abstract] [Full Text] [Related]

  • 38. [Expression of calgranulin A and B in middle ear cholesteatoma].
    Holly A, Bujía J, Lempart K, Serge M.
    Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.